Clinical Trial Name -A Pilot Study of Daptomycin for Antimicrobial Prophylaxis
| Original Study ID : Pro00000856 |
| Secondary ID : 19497 |
| NCT ID : NCT00572260 |
| Brief Title : A Pilot Study of Daptomycin for Antimicrobial Prophylaxis |
| Official Title : A Pilot Study of Daptomycin for Antimicrobial Prophylaxis in Patients Undergoing Cardiac Valve Replacement and Coronary Artery Bypass Grafting (CABG) Who Are at Increased Risk for Infection Due to Methicillin-Resistant Staphylococcus Aureus (MRSA) |
| Brief Summary :
The goals of the study are to evaluate the feasibility of using daptomycin as a prophylactic
antimicrobial agent in patients undergoing cardiac surgery, to determine the rates of
surgical site infection, and to evaluate the occurrence of adverse events.
|
| Source : Duke University |
| Overall Status : Terminated |
| Start Date : December 2007 |
| End Date : May 2008 |
| Completion Date : May 2008 |
| Official Title : Phase 4 |
| Phase : Interventional |
| Study Design : Treatment, Non-Randomized, Open Label, Historical Control, Factorial Assignment, Efficacy Study |
| Enrollment : 200 |
| Verification Date : November 2008 |
| First Received Date : December 12, 2007 |
| Trial Eligibility |
Criteria :
Inclusion Criteria:
|
| Gender : Both |
| Minimum Age : 18 Years |
| Maximum Age : N/A |
| Healthy Volunteers : No |
| Facilities |
| Facility Name : Duke University Medical Center |
| City : Durham |
| State : North Carolina |
| Zip Code : 27710 |
| Country : United States |
